The Cardiovascular Management of Sepsis

  • B. C. Creagh-Brown
  • J. Ball
  • M. Hamilton
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 2008)

Abstract

Sepsis is defined as suspected or proven infection plus a systemic inflammatory response syndrome. Severe sepsis is sepsis with organ dysfunction. Septic shock is severe sepsis with hypotension, despite adequate fluid resuscitation [1] and often requires treatment with vasoactive agents.

Keywords

Septic Shock Severe Sepsis Fluid Responsiveness Septic Shock Patient Pulmonary Artery Occlusion Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bone RC, Balk RA, Cerra FB, et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655CrossRefPubMedGoogle Scholar
  2. 2.
    Vincent JL, Sakr Y, Sprung C, et al (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353CrossRefPubMedGoogle Scholar
  3. 3.
    Dellinger RP, Carlet JM, Masur H, et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873CrossRefPubMedGoogle Scholar
  4. 4.
    Rivers E, Nguyen B, Havstad S, et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377CrossRefPubMedGoogle Scholar
  5. 5.
    Jones AE, Focht A, Horton JM, et al (2007) Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock. Chest 132:425–432CrossRefPubMedGoogle Scholar
  6. 6.
    Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP (2006) A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 26:551–557CrossRefPubMedGoogle Scholar
  7. 7.
    Bagshaw SM, Bellomo R (2007) The influence of volume management on outcome. Curr Opin Crit Care 13:541–548CrossRefPubMedGoogle Scholar
  8. 8.
    Hollenberg SM, Ahrens TS, Annane D, et al (2004) Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med 32(suppl):S455–465CrossRefPubMedGoogle Scholar
  9. 9.
    Rudiger A, Singer M (2007) Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:1599–608CrossRefPubMedGoogle Scholar
  10. 10.
    Belcher E, Mitchell J, Evans T (2002) Myocardial dysfunction in sepsis: no role for NO? Heart 87:507–509CrossRefPubMedGoogle Scholar
  11. 11.
    Sibelius U, Grandel U, Buerke M, et al (2003) Leukotriene-mediated coronary vasoconstriction and loss of myocardial contractility evoked by low doses of Escherichia coli hemolysin in perfused rat hearts. Crit Care Med 31:683–688CrossRefPubMedGoogle Scholar
  12. 12.
    Ammann P, Fehr T, Minder EI, Gunter C (2001) Elevation of troponin I in sepsis and septic shock. Intensive Care Med 27:965–969CrossRefPubMedGoogle Scholar
  13. 13.
    Kim HW, Greenburg AG (2002) Nitric oxide scavenging, alone or with nitric oxide synthesis inhibition, modulates vascular hyporeactivity in rats with intraperitoneal sepsis. Shock 17:423–426CrossRefPubMedGoogle Scholar
  14. 14.
    Stephens R, Mythen M (2003) Resuscitation fluids and hyperchloraemic metabolic acidosis. Trauma 5:141–147CrossRefGoogle Scholar
  15. 15.
    Vincent JL, Gerlach H (2004) Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 32:S451–S454CrossRefPubMedGoogle Scholar
  16. 16.
    Michard F, Teboul JL (2002) Predicting fluid responsiveness in ICU patients: A critical analysis of the evidence. Chest 121:2000–2008CrossRefPubMedGoogle Scholar
  17. 17.
    Bendjelid K, Romand JA (2003) Fluid responsiveness in mechanically ventilated patients: A review of indices used in intensive care. Intensive Care Med 29:352–360CrossRefPubMedGoogle Scholar
  18. 18.
    Osman D, Ridel C, Ray P, et al (2007) Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med 35:64–68CrossRefPubMedGoogle Scholar
  19. 19.
    Pinsky MR (2007) Heart-lung interactions. Curr Opin Crit Care 13:528–531CrossRefPubMedGoogle Scholar
  20. 20.
    Monnet X, Rienzo M, Osman D, et al (2006) Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med 34:1402–1407CrossRefPubMedGoogle Scholar
  21. 21.
    Vincent JL (2006) A reappraisal for the use of pulmonary artery catheters. Crit Care 10(suppl 3): S1CrossRefPubMedGoogle Scholar
  22. 22.
    Harvey S, Harrison DA, Singer M, et al (2005) Assessment of the clinical effectiveness of the pulmonary artery catheter; a randomised controlled trial. Lancet 366:472–477CrossRefPubMedGoogle Scholar
  23. 23.
    Gattinoni L, Brazzi L, Pelosi P, et al (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333:1025–1032CrossRefPubMedGoogle Scholar
  24. 24.
    Krafft P, Steltzer H, Hiesmayr M, Klimscha W, Hammerle AF (1993) Mixed venous oxygen saturation in critically ill septic shock patients. The role of defined events. Chest 103:900–906CrossRefPubMedGoogle Scholar
  25. 25.
    Fink MP (2002) Bench-to-bedside review: Cytopathic hypoxia. Crit Care 6:491–499CrossRefPubMedGoogle Scholar
  26. 26.
    Bateman RM, Sharpe MD, Ellis CG (2003) Bench-to-bedside review: microvascular dysfunction in sepsis — hemodynamics, oxygen transport, and nitric oxide. Crit Care 7:359–373CrossRefPubMedGoogle Scholar
  27. 27.
    James JH, Luchette FA, McCarter FD, Fischer JE (1999) Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 354:505–08CrossRefPubMedGoogle Scholar
  28. 28.
    Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE (2005) Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 365:871–875CrossRefPubMedGoogle Scholar
  29. 29.
    Cusack RJ, Rhodes A, Lochhead P, et al (2002) The strong ion gap does not have prognostic value in critically ill patients in a mixed medical/surgical adult ICU. Intensive Care Med 28:864–869CrossRefPubMedGoogle Scholar
  30. 30.
    Mullner M, Urbanek B, Havel C, Losert H, Waechter F, Gamper G (2004) Vasopressors for shock. Cochrane Database Syst Rev: CD003709Google Scholar
  31. 31.
    Vincent JL (2006) Is the current management of severe sepsis and septic shock really evidence based? PLoS Med 3:e346CrossRefPubMedGoogle Scholar
  32. 32.
    Zanotti Cavazzoni SL, Dellinger RP (2006) Hemodynamic optimization of sepsis-induced tissue hypoperfusion. Crit Care 10(suppl 3):S2CrossRefPubMedGoogle Scholar
  33. 33.
    Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J (2000) Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139–2143CrossRefPubMedGoogle Scholar
  34. 34.
    Albanese J, Leone M, Garnier F, Bourgoin A, Antonini F, Martin C (2004) Renal effects of norepinephrine in septic and nonseptic patients. Chest 126:534–539CrossRefPubMedGoogle Scholar
  35. 35.
    Sakr Y, Reinhart K, Vincent JL et al (2006) Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 34:589–597CrossRefPubMedGoogle Scholar
  36. 36.
    Bracco D (2006) Pharmacologic support of the failing circulation: practice, education, evidence, and future directions. Crit Care Med 34:890–892CrossRefPubMedGoogle Scholar
  37. 37.
    Annane D, Vignon P, Renault A, et al (2007) Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 370:676–684CrossRefPubMedGoogle Scholar
  38. 38.
    Barrett LK, Singer M, Clapp LH (2007) Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 35:33–40CrossRefPubMedGoogle Scholar
  39. 39.
    Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29:487–493CrossRefPubMedGoogle Scholar
  40. 40.
    Leone M, Albanese J, Delmas A, Chaabane W, Garnier F, Martin C (2004) Terlipressin in catecholamine-resistant septic shock patients. Shock 22:314–319CrossRefPubMedGoogle Scholar
  41. 41.
    Russell JA, Cooper DJ, Walley KR, et al (2007) Vasopressin and Septic Shock Trial (VASST): baseline characteristics and organ dysfunction in vasopressor dependent patients with septic shock. Am J Respir Crit Care Med 167:A548 (abst)Google Scholar
  42. 42.
    Martin GS (2007) An update on Sepsis. Available at: http://www.medscape.com/viewarticle/558470. Accessed December 2007
  43. 43.
    Luckner G, Mayr V, Jochberger S, et al (2007) Comparison of two doses of arginine vasopressin in advanced vasodilatory shock. Crit Care Med 35:2280–2285CrossRefPubMedGoogle Scholar
  44. 44.
    Morelli A, De Castro S, Teboul JL, et al (2005) Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31:638–644CrossRefPubMedGoogle Scholar
  45. 45.
    Barraud D, Faivre V, Damy T, et al (2007) Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med 35:1376–1382CrossRefPubMedGoogle Scholar
  46. 46.
    Powell BP, De Keulenaer BL (2007) Levosimendan in septic shock: a case series. Br J Anaesth 99:447–448CrossRefPubMedGoogle Scholar
  47. 47.
    De Backer D, Taccone FS, Radermacher P (2007) Levosimendan in septic shock: another piece in the puzzle, but many pieces are still lacking. Intensive Care Med 33:403–405CrossRefPubMedGoogle Scholar
  48. 48.
    Singer M (2006) The key advance in the treatment of sepsis in the last 10 years...doing less. Crit Care 10:122CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • B. C. Creagh-Brown
    • 1
  • J. Ball
    • 1
  • M. Hamilton
    • 1
  1. 1.General Intensive Care UnitSt George’s HospitalLondonUK

Personalised recommendations